Suffering from Asthma? We need you!
K
Kirsten Kloepfer, MD
Primary Investigator
Overview
IU School of Medicine is researching how dehydroepiandrosterone (DHEA)
treatments, a supplement for a hormone that your body naturally produces, affect
people with asthma. Though DHEA is currently an over-the-counter
medication, researchers want to pinpoint its slow-release capability to help
patients with asthma.
Description
What is Involved
· Participation involves 11 study visits at IUPUI campus in Indianapolis, IN over the course of 6 weeks.
Study visits will include:
· Measurements of airway function and inflammation
· Oral capsule consumption
· Blood collection
Compensation
· Participants will be compensated for their time and could receive up to $1,590 for completing all study requirements
How to Participate
IF YOU ARE
INTERESTED IN PARTICIPATING IN THIS STUDY please complete the pre-screener
questions below to see if you qualify.
You
may also contact the study team directly at (317) 274-3380 or
email allaugh@iu.edu
Additional Information
Full
study title – Phase IIa Clinical Trial to Evaluate Pharmacokinetics and Safety
of Slow Release DHEA
Eligibility
You may be eligible for this study if you meet the following criteria:
-
Conditions:
asthma
-
Age: Between 18 Years - 50 Years
-
Gender: All
Inclusion criteria:
- Are 18-50 years of age
- Have asthma
- Have no known lung disease other than asthma
- Are not pregnant or breastfeeding
- Are currently a non-smoker
- Have asthma
- Have no known lung disease other than asthma
- Are not pregnant or breastfeeding
- Are currently a non-smoker
Updated on
20 Apr 2024.
Study ID: 15038
Pre-Screener
